HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.9
  1. Home
  2. /Compound

[(9Z,19Z,21Z)-2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27,29-tetraoxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25-heptaen-13-yl] acetate

HCID 6477971
New noteNew reactionRequest quotesPrint preview
Basic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
13553-79-2
Standard SMILES
COC1/C=C\OC2(C)Oc3c(C)c(O)c4c(c3C2=O)C(=O)C=C(NC(=O)/C(C)=C\C=C/C(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C)C4=O
InChIKey
BTVYFIMKUHNOBZ-QXMMDKDBSA-N
Molecular formula
C37H45NO12
Average molar mass
695.8 g/mol
Monoisotopic mass
695.29417587

Names & identifiers

Preferred name
[(9Z,19Z,21Z)-2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27,29-tetraoxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25-heptaen-13-yl] acetate
IUPAC
[(9Z,19Z,21Z)-2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27,29-tetraoxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25-heptaen-13-yl] acetate
English name
Rifamycin S
Molecular formula
C37H45NO12
Molecular weight
695.75

Names & synonyms

Rafamycin SC37H45NO12[(9Z,19Z,21Z)-2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27,29-tetraoxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25-heptaen-13-yl] acetateNSC144130(12Z,14E,24E)-5,17,19-trihydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,6,9,11-tetraoxo-1,2,6,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,6,9,11(2H)-tetrone, 5,17,19,21-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate (7CI,8CI)Rifamycin,4-dideoxy-1,4-dihydro-1,4-dioxo-2,11,13]trienimino)naphtho[2,1-b]furan-1,6,9,11(2H)-tetrone, -5,17,19,21-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate2,11,13]trienimino)naphtho[2,1-b]furan-1,6,9,11(2H)-tetrone, 5,17,19,21-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetateWLN: T C6 B65-24- A D E 2BC G& AV DV GV LO NO F&VM OU B&U D&U MHT&&TJ IQ J1 M1 QO1 R1 SOV1 T1 UQ V1

Properties

Computed structural properties

XLogP
4.1
Topological polar surface area
195 Ų
Hydrogen bond donors
4
Hydrogen bond acceptors
12
Rotatable bonds
3
Heavy atoms
50
Formal charge
0
Complexity
1,480

Experimental & physicochemical properties

LogP0.7

Physicochemical properties

Melting point
179 · 179-181°C (dec.)
alpha
20 · D20 +476° (c = 0.1 in methanol)
Boiling point
700.89 °C · 700.89°C (rough estimate)
Density
1.2387 · 1.2387 (rough estimate)
refractive index
1.663 · 1.6630 (estimate)
storage temp.
-20 °C · -20°C Freezer
solubility
Benzene (Slightly), Chloroform (Slightly), Methanol (Slightly)
form
Solid
pka
3.85 · 3.85±0.70(Predicted)
color
Orange to Dark Orange
λmax
390 nm · 390nm(MeOH)(lit.)
Merck
14 · 14,8217
InChIKey
BTVYFIMKUHNOBZ-ODRIEIDWSA-N

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

wgk
WGK 3
rtecs
KD1925000
hs_code
2941.90.1050
Toxicity
LD50 in mice (mg/kg): 122 i.v.; 258 i.p.; 3000 orally (Sensi, 1964)
Signal word
Warning
Symbol(GHS)
GHS08
Storage Class
11 - Combustible Solids
target organs
Kidney
Hazard statements
H371
REACH Registrations
Active
Hazard Classifications
STOT RE 2 Oral
Precautionary statements
P501-P260-P270-P264-P308+P311-P405

Chemistry & industry

Applications

UsesRifamycin S (Rifaximin EP Impurity E) is a semi-synthetic antibiotic.

Upstream & downstream products

Downstream products

Sodium 4-chlorobenzene sulfinate

Additional notes

DefinitionChEBI: Rifamycin S is an organic molecular entity.

Suppliers

Loading…

Open inquiries

Loading…

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
rifamycin
100722
Show more names
1,4-dideoxy-1,4-dihydro-1,4-dioxo-rifamycinrifomycinsnci144-130RIFAMYCIN SRIFAMPICIN SRifamycin S CRSRifaximin Impurity ERifamycin S USP/EP/BP

Database identifiers

CAS
13553-79-2
PubChem CID
6477971
SMILES
C1[C@H](C)[C@H](O)[C@@H](C)[C@H](O)[C@H](C)[C@H](C(=O)OC)[C@@H](C)[C@H](OC)C=CO[C@]2(C)C(=O)C3C4C(=O)C=C(NC(=O)C(C)=CC=1)C(=O)C=4C(O)=C(C)C=3O2 |c:38,t:21,40|
FDA UNII
53 N820JV · PI53N820JV
ATC code
7 AA13,D06AX15,J04AB03,S01AA16,S02AA12 · A07AA13,D06AX15,J04AB03,S01AA16,S02AA12
UNSPSC Code
51101500 · 51101500
NACRES
41 · NA.41
Symbol(GHS)
8 · GHS08
Signal word
Warning
Hazard statements
371 · H371
Precautionary statements
501 · P501-P260-P270-P264-P308+P311-P405
target organs
Kidney
WGK Germany
3 · WGK 3
RTECS
1925000 · KD1925000
HS Code
2941.9 · 2941.90.1050
Storage Class
11 · 11 - Combustible Solids
Hazard Classifications
2 Oral · STOT RE 2 Oral
Toxicity
50 in · LD50 in mice (mg/kg): 122 i.v.; 258 i.p.; 3000 orally (Sensi, 1964)
REACH Registrations
Active